FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to immunology, and can be used for treating herpes virus infections, where the antiviral agent used is an aqueous solution of fullerene dnC60. Antiviral activity in vitro of fullerene dnC60 solution studied on Vero culture. Experiments have shown that an aqueous solution of fullerene dnC60 shows manifested virucidal, preventive and therapeutic activity. A therapeutic effect in vivo is tested in a model of herpetic infection of mice. Treatment of animals with fullerene dnC60 solution statistically significant reduction of clinical manifestations of herpetic infection.
EFFECT: obtained results allow to conclude that the aqueous solution shows pronounced therapeutic activity against HSV-1 infection, wherein its therapeutic effect is comparable to the reference preparation ACV when used in 500 times less than the concentration.
4 cl, 6 dwg, 2 tbl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| USING POLYCARBOXYLIC FULLERENE DERIATIVE AS MICROBIOCIDAL ANTIVIRAL AGENT | 2012 |
|
RU2533232C2 |
| 2-AMINO-5,6-DIFLUOR-1-(BETA-D-RIBOFURANOSYL)-BENZIMIDAZOLE, METHOD FOR PRODUCTION AND ANTIVIRAL ACTIVITY IN TERMS OF HERPES SIMPLEX VIRUS TYPE I | 2016 |
|
RU2629670C2 |
| ANTIVIRAL AGENT AGAINST HERPES SIMPLEX VIRUS TYPE 1 | 2022 |
|
RU2782935C1 |
| 3-BUTYLTHIO-1-(BETA-D-2-DEOXYRIBOFURANOSYL)-5-PHENYL-(4H)-1,2,4-TRIAZOLE, SYNTHESIS, ANTI-HERPES VIRUS ACTION | 2023 |
|
RU2815137C1 |
| COMPOSITION FOR ATOPIC DERMATITIS THERAPY BASED ON FULLEREN | 2016 |
|
RU2641041C1 |
| ANTIVIRAL AGENT AGAINST HUMAN HERPESVIRUS TYPE I AND ENTEROVIRUS B | 2022 |
|
RU2798659C1 |
| AGENT FOR INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) AND CYTOMEGALOVIRUS (CMV) INFECTIONS AND METHOD OF THEIR INHIBITION | 2002 |
|
RU2196602C1 |
| DIMERIC DERIVATIVE OF NETROPSIN - 15-LYS-BIS-NETROPSIN AND COMBINATIONS BASED ON THEREOF POSSESSING ANTI-HERPETIC ACTIVITY | 2004 |
|
RU2265610C1 |
| METHOD FOR PRODUCTION OF FULLERENE WATER-SALT DISPERSIONS | 2015 |
|
RU2630561C2 |
| APPLICATION OF FULLERENE C60 AQUEOUS SOLUTION AS THERAPEUTIC AGENT AT ATOPIC DERMATITIS DISEASE | 2016 |
|
RU2641091C1 |
